Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Serveur d'exploration SilverBacteriV1

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.

Identifieur interne : 000979 ( Main/Corpus ); précédent : 000978; suivant : 000980

In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.

Auteurs : Amanda V. Arjoon ; Charlotte V. Saylor ; Meghan May

Source :

RBID : pubmed:23031072

English descriptors

Abstract

BACKGROUND

Mycoplasmosis is a common infection in human and veterinary medicine, and is associated with chronic inflammation and high morbidity. Mycoplasma species are often intrinsically resistant to many conventional antimicrobial therapies, and the resistance patterns of pathogenic mycoplasmas to commonly used medicinal (antimicrobial) plant extracts are currently unknown.

METHODS

Aqueous extracts, ethanol extracts, or oils of the targeted plant species and colloidal silver were prepared or purchased. Activity against the wall-less bacterial pathogen Mycoplasma mycoides subsp. capri was determined and compared to activities measured against Escherichia coli and Bacillus subtilis. Antimicrobial susceptibility testing was performed by broth microdilution assays. The lethal or inhibitory nature of each extract was determined by subculture into neat growth medium.

RESULTS

Growth of M. mycoides capri, E. coli, and B. subtilis was inhibited by elderberry extract, oregano oil, ethanol extract of oregano leaves, and ethanol extract of goldenseal root. No inhibition was seen with aqueous extract of astragalus or calendula oil. Growth of M. mycoides capri and B. subtilis was inhibited by ethanol extract of astragalus, whereas growth of E. coli was not. Similarly, M. mycoides capri and E. coli were inhibited by aqueous extract of thyme, but B. subtilis was unaffected. Only B. subtilis was inhibited by colloidal silver. Measured MICs ranged from 0.0003 mg/mL to 3.8 mg/mL. Bacteriostatic and bactericidal effects differed by species and extract.

CONCLUSIONS

The atypical pathogen M. mycoides capri was sensitive to extracts from many medicinal plants commonly used as antimicrobials in states of preparation and concentrations currently available for purchase in the United States and Europe. Variation in bacteriostatic and bactericidal activities between species and extracts indicates that multiple effecter compounds are present in these plant species.


DOI: 10.1186/1472-6882-12-169
PubMed: 23031072
PubMed Central: PMC3517410

Links to Exploration step

pubmed:23031072

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.</title>
<author>
<name sortKey="Arjoon, Amanda V" sort="Arjoon, Amanda V" uniqKey="Arjoon A" first="Amanda V" last="Arjoon">Amanda V. Arjoon</name>
<affiliation>
<nlm:affiliation>Department of Biological Sciences, Fisher College of Science and Mathematics, Towson University, Towson, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Saylor, Charlotte V" sort="Saylor, Charlotte V" uniqKey="Saylor C" first="Charlotte V" last="Saylor">Charlotte V. Saylor</name>
</author>
<author>
<name sortKey="May, Meghan" sort="May, Meghan" uniqKey="May M" first="Meghan" last="May">Meghan May</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:23031072</idno>
<idno type="pmid">23031072</idno>
<idno type="doi">10.1186/1472-6882-12-169</idno>
<idno type="pmc">PMC3517410</idno>
<idno type="wicri:Area/Main/Corpus">000979</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000979</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.</title>
<author>
<name sortKey="Arjoon, Amanda V" sort="Arjoon, Amanda V" uniqKey="Arjoon A" first="Amanda V" last="Arjoon">Amanda V. Arjoon</name>
<affiliation>
<nlm:affiliation>Department of Biological Sciences, Fisher College of Science and Mathematics, Towson University, Towson, MD, USA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Saylor, Charlotte V" sort="Saylor, Charlotte V" uniqKey="Saylor C" first="Charlotte V" last="Saylor">Charlotte V. Saylor</name>
</author>
<author>
<name sortKey="May, Meghan" sort="May, Meghan" uniqKey="May M" first="Meghan" last="May">Meghan May</name>
</author>
</analytic>
<series>
<title level="j">BMC complementary and alternative medicine</title>
<idno type="eISSN">1472-6882</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Bacillus subtilis (drug effects)</term>
<term>Bacillus subtilis (genetics)</term>
<term>Escherichia coli (drug effects)</term>
<term>Escherichia coli (growth & development)</term>
<term>Humans (MeSH)</term>
<term>Magnoliopsida (MeSH)</term>
<term>Microbial Sensitivity Tests (MeSH)</term>
<term>Mycoplasma Infections (drug therapy)</term>
<term>Mycoplasma Infections (microbiology)</term>
<term>Mycoplasma mycoides (drug effects)</term>
<term>Mycoplasma mycoides (growth & development)</term>
<term>Phytotherapy (MeSH)</term>
<term>Plant Extracts (pharmacology)</term>
<term>Plant Extracts (therapeutic use)</term>
<term>Plants, Medicinal (MeSH)</term>
<term>Ruminants (MeSH)</term>
<term>Silver (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Plant Extracts</term>
<term>Silver</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Plant Extracts</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Bacillus subtilis</term>
<term>Escherichia coli</term>
<term>Mycoplasma mycoides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Mycoplasma Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Bacillus subtilis</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Escherichia coli</term>
<term>Mycoplasma mycoides</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Mycoplasma Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Magnoliopsida</term>
<term>Microbial Sensitivity Tests</term>
<term>Phytotherapy</term>
<term>Plants, Medicinal</term>
<term>Ruminants</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Mycoplasmosis is a common infection in human and veterinary medicine, and is associated with chronic inflammation and high morbidity. Mycoplasma species are often intrinsically resistant to many conventional antimicrobial therapies, and the resistance patterns of pathogenic mycoplasmas to commonly used medicinal (antimicrobial) plant extracts are currently unknown.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Aqueous extracts, ethanol extracts, or oils of the targeted plant species and colloidal silver were prepared or purchased. Activity against the wall-less bacterial pathogen Mycoplasma mycoides subsp. capri was determined and compared to activities measured against Escherichia coli and Bacillus subtilis. Antimicrobial susceptibility testing was performed by broth microdilution assays. The lethal or inhibitory nature of each extract was determined by subculture into neat growth medium.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Growth of M. mycoides capri, E. coli, and B. subtilis was inhibited by elderberry extract, oregano oil, ethanol extract of oregano leaves, and ethanol extract of goldenseal root. No inhibition was seen with aqueous extract of astragalus or calendula oil. Growth of M. mycoides capri and B. subtilis was inhibited by ethanol extract of astragalus, whereas growth of E. coli was not. Similarly, M. mycoides capri and E. coli were inhibited by aqueous extract of thyme, but B. subtilis was unaffected. Only B. subtilis was inhibited by colloidal silver. Measured MICs ranged from 0.0003 mg/mL to 3.8 mg/mL. Bacteriostatic and bactericidal effects differed by species and extract.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>The atypical pathogen M. mycoides capri was sensitive to extracts from many medicinal plants commonly used as antimicrobials in states of preparation and concentrations currently available for purchase in the United States and Europe. Variation in bacteriostatic and bactericidal activities between species and extracts indicates that multiple effecter compounds are present in these plant species.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23031072</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>05</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1472-6882</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>12</Volume>
<PubDate>
<Year>2012</Year>
<Month>Oct</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>BMC complementary and alternative medicine</Title>
<ISOAbbreviation>BMC Complement Altern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.</ArticleTitle>
<Pagination>
<MedlinePgn>169</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6882-12-169</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mycoplasmosis is a common infection in human and veterinary medicine, and is associated with chronic inflammation and high morbidity. Mycoplasma species are often intrinsically resistant to many conventional antimicrobial therapies, and the resistance patterns of pathogenic mycoplasmas to commonly used medicinal (antimicrobial) plant extracts are currently unknown.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Aqueous extracts, ethanol extracts, or oils of the targeted plant species and colloidal silver were prepared or purchased. Activity against the wall-less bacterial pathogen Mycoplasma mycoides subsp. capri was determined and compared to activities measured against Escherichia coli and Bacillus subtilis. Antimicrobial susceptibility testing was performed by broth microdilution assays. The lethal or inhibitory nature of each extract was determined by subculture into neat growth medium.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Growth of M. mycoides capri, E. coli, and B. subtilis was inhibited by elderberry extract, oregano oil, ethanol extract of oregano leaves, and ethanol extract of goldenseal root. No inhibition was seen with aqueous extract of astragalus or calendula oil. Growth of M. mycoides capri and B. subtilis was inhibited by ethanol extract of astragalus, whereas growth of E. coli was not. Similarly, M. mycoides capri and E. coli were inhibited by aqueous extract of thyme, but B. subtilis was unaffected. Only B. subtilis was inhibited by colloidal silver. Measured MICs ranged from 0.0003 mg/mL to 3.8 mg/mL. Bacteriostatic and bactericidal effects differed by species and extract.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The atypical pathogen M. mycoides capri was sensitive to extracts from many medicinal plants commonly used as antimicrobials in states of preparation and concentrations currently available for purchase in the United States and Europe. Variation in bacteriostatic and bactericidal activities between species and extracts indicates that multiple effecter compounds are present in these plant species.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arjoon</LastName>
<ForeName>Amanda V</ForeName>
<Initials>AV</Initials>
<AffiliationInfo>
<Affiliation>Department of Biological Sciences, Fisher College of Science and Mathematics, Towson University, Towson, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Saylor</LastName>
<ForeName>Charlotte V</ForeName>
<Initials>CV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>May</LastName>
<ForeName>Meghan</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>10</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Complement Altern Med</MedlineTA>
<NlmUniqueID>101088661</NlmUniqueID>
<ISSNLinking>1472-6882</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3M4G523W1G</RegistryNumber>
<NameOfSubstance UI="D012834">Silver</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001412" MajorTopicYN="N">Bacillus subtilis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019684" MajorTopicYN="Y">Magnoliopsida</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009175" MajorTopicYN="N">Mycoplasma Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009176" MajorTopicYN="N">Mycoplasma mycoides</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008517" MajorTopicYN="N">Phytotherapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010946" MajorTopicYN="Y">Plants, Medicinal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012418" MajorTopicYN="N">Ruminants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012834" MajorTopicYN="N">Silver</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>04</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>09</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>10</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>10</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23031072</ArticleId>
<ArticleId IdType="pii">1472-6882-12-169</ArticleId>
<ArticleId IdType="doi">10.1186/1472-6882-12-169</ArticleId>
<ArticleId IdType="pmc">PMC3517410</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Pharm Biol. 2010 Oct;48(10):1103-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20819025</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Cancer. 2006;6:119</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16677386</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Planta Med. 1997 Jun;63(3):196-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9225598</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Bacteriol. 1945 Jun;49(6):611-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16560960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phytother Res. 2004 Mar;18(3):212-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15103668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Cir Bras. 2011 Feb;26(1):19-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21271199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Anim Health Prod. 2007 Oct;39(7):515-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17969714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Drugs Dermatol. 2010 Apr;9(4):377-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20514796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Bacteriol. 1989 Apr;66(4):301-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2666376</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Poult Sci. 2004 Oct;45(5):684-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15623224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>APMIS. 2005 Jan;113(1):1-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15676008</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Planta Med. 2001 Aug;67(6):561-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11509983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Altern Med Rev. 1998 Oct;3(5):338-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9802911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Bacteriol. 1984 Aug;57(1):179-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6490561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Complement Altern Med. 2011;11:16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21352539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Evid Based Complement Alternat Med. 2012;2012:375671</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22315631</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Skin Pharmacol Physiol. 2005 Jul-Aug;18(4):195-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15908760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Molecules. 2010 Nov;15(11):7532-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21030907</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Microbiol. 2001 Sep;91(3):453-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11556910</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 2011 Jul;24(3):498-514</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21734246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vet Microbiol. 2007 Jan 17;119(1):72-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16978803</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Physiol Pharmacol Bulg. 1982;8(4):63-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7185264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11420333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anaerobe. 2011 Dec;17(6):399-402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21521657</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ethnopharmacol. 2009 Dec 10;126(3):463-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19781615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biochem. 2004 Oct;265(1-2):19-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15543930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Spectrochim Acta A Mol Biomol Spectrosc. 2012 Jun;91:234-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22381796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEMS Microbiol Rev. 2008 Nov;32(6):956-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18754792</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Altern Complement Med. 2011 Sep;17(9):835-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21854197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Rev. 1999 Oct;12(4):564-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10515903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trop Anim Health Prod. 2006 Jan;38(1):1-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17405622</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Pharm Fr. 1980;38(6):493-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7283346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Food Microbiol. 1988 May;6(3):263-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2978951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ethnopharmacol. 2000 Jun;70(3):343-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10837997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000979 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000979 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Terre
   |area=    SilverBacteriV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:23031072
   |texte=   In Vitro efficacy of antimicrobial extracts against the atypical ruminant pathogen Mycoplasma mycoides subsp. capri.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:23031072" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SilverBacteriV1
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 1 22:59:42 2021. Site generation: Mon Feb 1 23:01:29 2021